Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Now: Patients can obtain Zepbound at significantly reduced rates , potentially saving hundreds of dollars per month
Metformin adverse event profile: A pharmacovigilance study based on the FDA adverse event reporting system (FAERS) from 2004 to 2022
Even worse: Based in part on those misses, Lilly lowered the high end of its revenue forecast or guidance to investors for 2024 by 1.3% from $46.6 billion to an even $46 billion, while keeping the low end intact at $45.4 billion
Key highlights:- Cipla & Emcure Partnerships: Cipla's deal brings semaglutide to market, while Emcure eyes tirzepatide
US$ 23.80
US$ 26.08
US$ 26.36
US$ 22.25
US$ 24.03
US$ 28.73
US$ 22.58
US$ 26.39
US$ 23.94
US$ 24.97
